The effects of prenatal exposure to valproic acid on the initial development of serotonergic neurons

International Journal of Developmental Neuroscience

Volumn 31, Issue 3, 2013, Pages 202-208

  Oyabu, Akiko ^a   Narita, Masaaki ^a   Tashiro, Yasura ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Autism; Development; Raphe nuclei; Rat embryo; Serotonin neuron; Valproic acid

Indexed keywords

FIBROBLAST GROWTH FACTOR 8; MESSENGER RNA; SONIC HEDGEHOG PROTEIN; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; PRENATAL DEVELOPMENT; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAPHE NUCLEUS; RAT; RHOMBENCEPHALIC ISTHMUS; RHOMBENCEPHALON; ROSTRAL RAPHE NUCLEUS; SEROTONINERGIC NERVE CELL;

ANIMALS; FEMALE; HEDGEHOG PROTEINS; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RAPHE NUCLEI; RATS; RATS, WISTAR; SEROTONERGIC NEURONS; VALPROIC ACID;

EID: 84873885108     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2013.01.006     Document Type: Article

References (41)

1. Abrams J.K., Johnson P.L., Hollis J.H., Lowry C.A. Anatomic and functional topography of the dorsal raphe nucleus. Annals of the New York Academy of Sciences 2004, 1018:46-57.
2. Aitken A.R., Törk I. Early development of serotonin-containing neurons and pathways as seen in wholemount preparations of the fetal rat brain. Journal of Comparative Neurology 1988, 274:32-47.
3. Aoto K., Shikata Y., Higashiyama D., Shiota K., Motoyama J. Fetal ethanol exposure activates protein kinase A and impairs Shh expression in prechordal mesendoderm cells in the pathogenesis of holoprosencephaly. Birth Defects Research Part A: Clinical and Molecular Teratology 2008, 82:224-231.
4. Arndt T.L., Stodgell C.J., Rodier P.M. The teratology of autism. International Journal of Developmental Neuroscience 2005, 23:189-199.
5. Basson M.A., Echevarria D., Ahn C.P., Sudarov A., Joyner A.L., Mason I.J., Martinez S., Martin G.R. Specific regions within the embryonic midbrain and cerebellum require different levels of FGF signaling during development. Development 2008, 135:889-898.
6. Bonnin A., Levitt P. Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain. Neuroscience 2011, 197:1-7.
7. Bromley, Mawer R.L., Clayton-Smith G., Baker J. Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 2008, 71:1923-1924. Liverpool and Manchester Neurodevelopment Group.
8. Duchan E., Patel D.R. Epidemiology of autism spectrum disorders. Pediatric Clinics of North America 2012, 59:27-43.
9. Dufour-Rainfray D., Vourc'h P., Le Guisquet A.M., Garreau L., Ternant D., Bodard S., Jaumain E., Gulhan Z., Belzung C., Andres C.R., Chalon S., Guilloteau D. Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism. Neuroscience Letters 2010, 470:55-59.
10. Filipek P.A., Accardo P.J., Baranek G.T., Cook E.H., Dawson G., Gordon B., Gravel J.S., Johnson C.P., Kallen R.J., Levy S.E., Minshew N.J., Ozonoff S., Prizant B.M., Rapin I., Rogers S.J., Stone W.L., Teplin S., Tuchman R.F., Volkmar F.R. The screening and diagnosis of autistic spectrum disorders. Journal of Autism and Developmental Disorders 1999, 29:439-484.
11. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nature Reviews Neuroscience 2003, (4):1002-1012.
12. Gos T., Krell D., Brisch R., Bielau H., Trübner K., Steiner J., Bernstein H.G., Bogerts B. Demonstration of decreased activity of dorsal raphe nucleus neurons in depressed suicidal patients by the AgNOR staining method. Journal of Affective Disorders 2008, 111:251-260.
13. Hynes M., Rosenthal A. Specification of dopaminergic and serotonergic neurons in the vertebrate CNS. Current Opinion in Neurobiology 1999, 9:26-36.
14. Janušonis S., Gluncic V., Rakic P. Early serotonergic projections to Cajal-Retzius cells: relevance for cortical development. The Journal of Neuroscience 2004, 24:1652-1659.
15. Kiyasova V., Gaspar P. Development of raphe serotonin neurons from specification to guidance. European Journal of Neuroscience 2011, 34:1553-1562.
16. König N., Wilkie M.B., Lauder J.M. Tyrosine hydroxylase and serotonin containing cells in embryonic rat rhombencephalon: a whole-mount immunocytochemical study. Journal of Neuroscience Research 1988, 20:212-223.
17. Lauder J.M., Bloom F.E. Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. I. Cell differentiation. Journal of Comparative Neurology 1974, 155:469-481.
18. Leboyer M., Philippe A., Bouvard M., Guilloud-Bataille M., Bondoux D., Tabuteau F., Feingold J., Mouren-Simeoni M.C., Launay J.M. Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives. Biological Psychiatry 1999, 45:158-163.
19. Leskovec T.J., Rowles B.M., Findling R.L. Pharmacological treatment options for autism spectrum disorders in children and adolescents. Harvard Review of Psychiatry 2008, 16:97-112.
20. Machold R., Hayashi S., Rutlin M., Muzumdar M.D., Nery S., Corbin J.G., Gritli-Linde A., Dellovade T., Porter J.A., Rubin L.L., Dudek H., McMahon A.P., Fishell G. Sonic hedgehog is required for progenitor cell maintenance in telencephalic stem cell niches. Neuron 2003, 39:937-950.
21. Miyazaki K., Narita N., Narita M. Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism. International Journal of Developmental Neuroscience 2005, 23:287-297.
22. Monti J.M. Serotonin control of sleep-wake behavior. Sleep Medicine Reviews 2011, 15:269-281.
23. Moore S.J., Turnpenny P., Quinn A., Glover S., Lloyd D.J., Montgomery T., Dean J.C. A clinical study of 57 children with fetal anticonvulsant syndromes. Journal of Medical Genetics 2000, 37:489-497.
24. Nakatani J., Tamada K., Hatanaka F., Ise S., Ohta H., Inoue K., Tomonaga S., Watanabe Y., Chung Y.J., Banerjee R., Iwamoto K., Kato T., Okazawa M., Yamauchi K., Tanda K., Takao K., Miyakawa T., Bradley A., Takumi T. Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell 2009, 137:1235-1246.
25. Narita N., Kato M., Tazoe M., Miyazaki K., Narita M., Okado N. Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism. Pediatric Research 2002, 52:576-579.
26. Nieto M.A., Patel K., Wilkinson D.G. In situ hybridization analysis of chick embryos in whole mount and tissue sections. Methods in Cell Biology 1996, 51:219-235.
27. Oyabu A., Tashiro Y., Oyama T., Ujihara K., Ohkawara T., Ida-Eto M., Narita M. Morphology of the facial motor nuclei in a rat model of autism during early development. International Journal of Developmental Neuroscience 2013, 31:138-144.
28. Peça J., Feliciano C., Ting J.T., Wang W., Wells M.F., Venkatraman T.N., Lascola C.D., Fu Z., Feng G. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 2011, 472:437-442.
29. Rasalam A.D., Hailey H., Williams J.H., Moore S.J., Turnpenny P.D., Lloyd D.J., Dean J.C. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Developmental Medicine & Child Neurology 2005, 47:551-555.
30. Rice D., Barone S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environmental Health Perspectives 2000, 108(Suppl. 3):511-533.
31. Sadamatsu M., Kanai H., Xu X., Liu Y., Kato N. Review of animal models for autism: implication of thyroid hormone. Congenital Anomalies 2006, 46:1-9.
32. Scott M.M., Deneris E.S. Making and breaking serotonin neurons and autism. International Journal of Developmental Neuroscience 2005, 23:277-285.
33. Tashiro Y., Yanagawa Y., Obata K., Murakami F. Development and migration of GABAergic neurons in the mouse myelencephalon. Journal of Comparative Neurology 2007, 503:260-269.
34. Tashiro Y., Oyabu A., Imura Y., Uchida A., Narita N., Narita M. Morphological abnormalities of embryonic cranial nerves after in utero exposure to valproic acid: implications for the pathogenesis of autism with multiple developmental anomalies. International Journal of Developmental Neuroscience 2011, 29:359-364.
35. Tsujino N., Nakatani Y., Seki Y., Nakasato A., Nakamura M., Sugawara M., Arita H. Abnormality of circadian rhythm accompanied by an increase in frontal cortex serotonin in animal model of autism. Neuroscience Research 2007, 57:289-295.
36. Warren Z., McPheeters M.L., Sathe N., Foss-Feig J.H., Glasser A., Veenstra-Vanderweele J. A systematic review of early intensive intervention for autism spectrum disorders. Pediatrics 2011, 127:e1303-e1311.
37. Wegiel J., Kuchna I., Nowicki K., Imaki H., Marchi E., Ma S.Y., Chauhan A., Chauhan V., Bobrowicz T.W., de Leon M., Louis L.A., Cohen I.L., London E., Brown W.T., Wisniewski T. The neuropathology of autism: defects of neurogenesis and neuronal migration and dysplastic changes. Acta Neuropathologica 2010, 119:755-770.
38. Wurst W., Bally-Cuif L. Neural plate patterning: upstream and downstream of the isthmic organizer. Nature Reviews Neuroscience 2001, 2:99-108.
39. Yamamoto M., Schwarting G. The formation of axonal pathways in developing cranial nerves. Neuroscience Research 1991, 11:229-260.
40. Ye W., Shimamura K., Rubenstein J.L., Hynes M.A., Rosenthal A. FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 1998, 93:755-766.
41. Zhou F.C., Sari Y., Zhang J.K., Goodlett C.R., Li T. Prenatal alcohol exposure retards the migration and development of serotonin neurons in fetal C57BL mice. Developmental Brain Research 2001, 126:147-155.